Company Overview
Shoreline Biosciences is a clinical-stage biotechnology company harnessing induced pluripotent stem cells (iPSCs) to develop allogeneic, off-the-shelf cellular immunotherapies. The company differentiates iPSCs into natural killer (iNK) cells and macrophages (iMACs) engineered to attack cancer and autoimmune targets. Its proprietary SLEEK knock-in gene-editing technology and industry-leading SMART manufacturing platform are designed to produce scalable, affordable cell therapies without donor matching constraints. Shoreline has raised $183M in equity across two rounds from 18 investors and has secured corporate partnerships valued at over $300M in aggregate support. The pipeline spans both solid tumors and hematologic malignancies, with autoimmune disorder programs announced in late 2024.
Key Differentiators
Emerging Innovator
Shoreline Biosciences is an emerging player bringing innovative solutions to the Life Sciences & BioTech market.
Frequently Asked Questions
Similar Brands
Pliant Therapeutics
Pliant Therapeutics develops small molecule integrin inhibitors targeting the pathological tissue scarring (fibrosis) that drives diseases including idiopathic pulmonary fibrosis (IPF), primary sclero
Cradle
Cradle is a protein design platform using AI to help biotechnology and pharmaceutical companies engineer better proteins — enzymes, antibodies, and therapeutic proteins — with improved stability, acti
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
BioNTech
BioNTech SE was founded in 2008 in Mainz, Germany by Ugur Sahin, Ozlem Tureci, and Christoph Huber with a mission to harness the immune system for individualized cancer treatment. The company pioneere
Genentech
Genentech was founded in 1976 in South San Francisco by Herbert Boyer and Robert Swanson, becoming the first company to produce human insulin using recombinant DNA technology and essentially launching
Illumina
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat
Compare Shoreline Biosciences with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Shoreline Biosciences? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Shoreline Biosciences Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Shoreline Biosciences vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →